降钙素原指导成人疑似细菌感染与脓毒症抗菌药物使用的成本效果分析
该研究将真实世界结果纳入预测模型,评估降钙素原(PCT)指导成人脓毒症患者抗菌药物使用的成本效果。单中心回顾性横断面研究显示,PCT指导治疗路径可使每例患者节省45美元医院成本,并增加0.0001质量调整生命年;排除不符合机构指南的PCT检测后,干预后组抗菌治疗持续时间显著缩短(6.2天 vs 4.9天,p=0.04),预测年总节省4,840美元。
要点
- PCT指导抗菌药物使用可能降低医院成本并改善生活质量。
- 干预后抗菌治疗持续时间显著缩短(6.2天 vs 4.9天,p=0.04)。
- 每例患者预测节省45美元,年总节省4,840美元。
核心结论
- PCT指导的抗菌药物使用在MICU未分化脓毒症患者中可能改善生活质量并降低医院成本。
研究设计与样本
- 单中心回顾性横断面研究,将真实世界结果纳入决策分析模型,从医院视角进行成本最小化和成本效用分析,时间跨度1年。
主要发现
- 基础案例模型预测PCT指导治疗算法每例患者节省45美元医院成本,增加0.0001质量调整生命年。
- 排除不符合机构指南的PCT检测后,干预后组平均住院抗菌治疗持续时间显著短于干预前组(6.2天 vs 4.9天,p=0.04),已调整患者性别、年龄、Charlson合并症指数评分、研究期间、血管加压药使用和呼吸机使用。
- 预测年总医院成本节省4,840美元。
临床怎么用
- 在MICU脓毒症患者中可考虑采用PCT指导的治疗路径以缩短抗菌治疗持续时间并节省成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Results of a study incorporating real-world results into a predictive model to assess the cost-effectiveness of procalcitonin (PCT)-guided antibiotic use in intensive care unit patients with sepsis are reported. METHODS: A single-center, retrospective cross-sectional study was conducted to determine whether reductions in antibiotic therapy duration and other care improvements resulting from PCT testing and use of an associated treatment pathway offset the costs of PCT testing. Selected base-case cost outcomes in adults with sepsis admitted to a medical intensive care unit (MICU) were assessed in preintervention and postintervention cohorts using a decision analytic model. Cost-minimization and cost-utility analyses were performed from the hospital perspective with a 1-year time horizon. Secondary and univariate sensitivity analyses tested a variety of clinically relevant scenarios and the robustness of the model. RESULTS: Base-case modeling predicted that use of a PCT-guided treatment algorithm would results in hospital cost savings of $45 per patient and result in a gain of 0.0001 quality-adjusted life-year. After exclusion of patients in the postintervention cohort for PCT test ordering outside of institutional guidelines, the mean inpatient antibiotic therapy duration was significantly reduced in the postintervention group relative to the preintervention group (6.2 days versus 4.9 days, p = 0.04) after adjustment for patient sex and age, Charlson Comorbidity Index score, study period, vasopressor use, and ventilator use. Total annual hospital cost savings of $4,840 were predicted. CONCLUSION: Real-world implementation of PCT-guided antibiotic use may have improved patients' quality of life while decreasing hospital costs in MICU patients with undifferentiated sepsis.
引用
- Collins CD, Brockhaus K, Sim T, et al. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis. Am J Health Syst Pharm. 2019. PMID: 31369118. doi:10.1093/ajhp/zxz129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。